论文信息 - Increases in leucocyte and platelet counts induced by the alkyl phospholipid hexadecylphosphocholine. - 字舞流文

Increases in leucocyte and platelet counts induced by the alkyl phospholipid hexadecylphosphocholine.

J. Verweij | G. Stoter | L. Pronk | R. Oosterom | A. Planting | T. Drogendijk

[1] H. Sindermann,et al. Phase I Study of Weekly Oral Miltefosine (Hexadecyl-Phosphocholine) in Cancer Patients , 1991 .

[2] C. Unger,et al. Hexadecylphosphocholine: a new and selective antitumor drug. , 1990, Cancer treatment reviews.

[3] C. Unger,et al. Characterization of the antitumor activity of hexadecylphosphocholine (D 18506). , 1988, European journal of cancer & clinical oncology.

[4] J. Hickman. Membrane targets in cancer chemotherapy. , 1988, European journal of cancer & clinical oncology.

[5] J. Verweij,et al. Phase II study of daily oral miltefosine (hexadecylphosphocholine) in advanced colorectal cancer. , 1993, European journal of cancer.

[6] M. van Glabbeke,et al. Phase II study of miltefosine (hexadecylphosphocholine) in advanced soft tissue sarcomas of the adult--an EORTC Soft Tissue and Bone Sarcoma Group Study. , 1993, European journal of cancer.

[7] J. Verweij,et al. Phase II study of oral miltefosine in patients with squamous cell head and neck cancer. , 1993, European journal of cancer.

[8] C. Unger,et al. Hexadecylphosphocholine stimulates the colony-stimulating factor-dependent growth of hemopoietic progenitor cells. , 1992, Experimental hematology.

[9] C. Unger,et al. Hexadecylphosphocholine, a new ether lipid analogue. Studies on the antineoplastic activity in vitro and in vivo. , 1989, Acta oncologica.